T32 Training Program in Mechanisms and Innovation in Vascular Disease

T32血管疾病机制与创新培训项目

• 批准号: 10450636
• 负责人: Nicholas James Leeper
• 金额: $ 46.27万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-07-01 至 2025-06-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10450636
• 关键词: Training Programs; Vascular Diseases; innovation

Project Summary This T32 translational vascular research training program builds on the capabilities of the Stanford Cardiovascular Institute, which provides valuable unique and innovative professional development opportunities to a diverse group of promising early career investigators in vascular disease management. It supports NHLBI’s mission to develop novel integrative strategies to prevent, diagnose, and treat cardiovascular diseases, while at the same time fulfilling its educational goal to train tomorrow’s leaders in basic, translational, and applied vascular research. This T32 is Stanford's only University-wide effort to develop the next generation of translational vascular investigators. The program goals include rigorous training in the scientific method, critical analysis, logical reasoning and independent thinking in a highly collaborative, multidisciplinary setting. Trainees develop a focused area of vascular research expertise and are exposed to a wide range of complementary research techniques. Mentors model collegial and productive collaboration provide guidance in oral and written communication and instill respect for the responsible conduct of research. Our past trainees have gone on to become independent researchers in premier academic institutions and in industry and are emerging leaders in the field of vascular research. The program proposes to continue training 6 postdoctoral fellows in multidisciplinary vascular research. Fellows are appointed to this T32 annually, with a strong encouragement to seek their own funding for additional years as part of the skills imparted by the program. 31 trainees so far have benefited from this program, including 18 women and 4 underrepresented minorities. Six are currently in training. Evaluations suggest a high degree of satisfaction with the program. The Program is directed by Philip Tsao, PhD (Contact PI), Professor of Medicine, Stanford University School of Medicine; Associate Chief of Staff -Precision Medicine, VA Palo Alto Health Care System, and Nicholas Leeper, MD, Professor of Surgery and Medicine; Chief, Vascular Medicine, Stanford. Administrative and program management support is provided by a dedicated team of educators in the Stanford Cardiovascular Institute. An Internal Advisory Board consisting of senior Stanford faculty from a broad range of disciplines and an External Advisory Board consisting of leading experts in vascular medicine and research in the US play a vital role in monitoring the progress of this training program, providing ongoing support and advice as needed. Our overarching goal is to train the next generation of investigators in vascular research, and to facilitate their transition into productive and successful academic and industry leaders.

项目概要 这个 T32 转化血管研究培训计划建立在斯坦福大学的能力之上 心血管研究所，提供宝贵的独特和创新的专业发展机会 它支持 NHLBI 的血管疾病管理领域的多元化早期职业研究人员。 使命是开发新的综合策略来预防、诊断和治疗心血管疾病，同时 同时实现其教育目标，培养基础、转化和应用血管方面的未来领导者 这项 T32 是斯坦福大学范围内唯一致力于开发下一代转化的研究。 该计划的目标包括对科学方法、批判性分析、 受训者在高度协作、多学科的环境中发展逻辑推理和独立思考。 血管研究专业知识的重点领域，并接触广泛的补充研究 导师示范大学和富有成效的合作提供口头和书面指导。 我们过去的学员继续进行沟通并灌输对负责任的研究行为的尊重。 成为一流学术机构和工业界的独立研究人员，并成为新兴领域的领导者 血管研究领域。 该项目拟继续培养6名多学科血管研究博士后。 每年被任命为 T32 成员，强烈鼓励他们在额外的年份里寻求自己的资金 作为该方案传授技能的一部分，迄今为止已有 31 名受训者从该方案中受益，其中包括 18 名。 妇女和 4 个代表性不足的少数群体目前正在接受培训。 该计划由医学教授 Philip Tsao 博士（联系人 PI）指导。 斯坦福大学医学院副主任 - 弗吉尼亚州帕洛阿尔托医疗保健精准医学 System 和尼古拉斯·利珀 (Nicholas Leeper) 医学博士，斯坦福大学血管医学主任教授。 斯坦福大学专门的教育工作者团队提供行政和项目管理支持 心血管研究所。内部顾问委员会由来自各个领域的斯坦福大学高级教师组成。 学科和外部顾问委员会由血管医学和研究领域的领先专家组成 美国在监测该培训计划的进展、提供持续的支持和建议方面发挥着至关重要的作用 根据需要，我们的总体目标是培训下一代血管研究人员，以及 促进他们转变为富有成效和成功的学术和行业领导者。